{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:18:48Z","timestamp":1790745528653,"version":"4.1.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,3,14]]},"DOI":"10.18632\/oncotarget.14846","type":"journal-article","created":{"date-parts":[[2017,1,29]],"date-time":"2017-01-29T01:19:13Z","timestamp":1485652753000},"page":"17763-17770","source":"Crossref","is-referenced-by-count":46,"title":["Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling"],"prefix":"10.18632","volume":"8","author":[{"given":"Ming","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Health Science Centre, Peking University, Beijing, China"},{"name":"Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ashton-Key","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Southampton University Hospitals National Health Service Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eguzkine","family":"Ochoa","sequence":"additional","affiliation":[{"name":"Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccolo","family":"Bolli","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK"},{"name":"Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy"},{"name":"Department of Hematology and Pediatric Onco-Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vassiliou","sequence":"additional","affiliation":[{"name":"Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifen","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Health Science Centre, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qing","family":"Du","sequence":"additional","affiliation":[{"name":"Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.semdp.2011.03.003","article-title":"Follicular helper T cells: implications in neoplastic hematopathology","volume":"28","author":"de Leval","year":"2011","journal-title":"Semin Diagn Pathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bjh.12941","article-title":"Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment","volume":"166","author":"Wagner","year":"2014","journal-title":"Br J Haematol"},{"key":"3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Chott","year":"2006","journal-title":"Leukemia"},{"key":"4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Haioun","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","article-title":"ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma","volume":"37","author":"Dogan","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","article-title":"The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma","volume":"207","author":"Ruland","year":"2010","journal-title":"J Exp Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-08-3719","article-title":"The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease","volume":"70","author":"Veelken","year":"2010","journal-title":"Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Nicolas","year":"2014","journal-title":"Nat Genet"},{"key":"9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Nakamoto-Matsubara","year":"2014","journal-title":"Nat Genet"},{"key":"10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Ju","year":"2014","journal-title":"Nat Genet"},{"key":"11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Louissaint","year":"2014","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Gaulard","year":"2012","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Bernard","year":"2012","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Mottok","year":"2016","journal-title":"Leukemia"},{"key":"15","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Cannon","year":"2015","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2013-05-504308","article-title":"PLCG1 mutations in cutaneous T-cell lymphomas","volume":"123","author":"Martin-Sanchez","year":"2014","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3324\/haematol.2014.113696","article-title":"Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas","volume":"100","author":"Perez-Seoane","year":"2015","journal-title":"Haematologica"},{"key":"18","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.str.2012.09.005","article-title":"Structural and functional integration of the PLCgamma interaction domains critical for regulatory mechanisms and signaling deregulation","volume":"20","author":"Katan","year":"2012","journal-title":"Structure"},{"key":"19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nsmb.2752","article-title":"Competition between Grb2 and Plcgamma1 for FGFR2 regulates basal phospholipase activity and invasion","volume":"21","author":"Ladbury","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2921","article-title":"Recurrent PTPRB and PLCG1 mutations in angiosarcoma","volume":"46","author":"Koss","year":"2014","journal-title":"Nat Genet"},{"key":"21","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Fabiani","year":"2016","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/978-0-387-89520-8_13","article-title":"Tumor necrosis factor receptor superfamily member 21. TNFR-related death receptor-6, DR6","volume":"647","author":"Na","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.molimm.2011.03.021","article-title":"T-cell activation triggers death receptor-6 expression in a NF-kappaB and NF-AT dependent manner","volume":"48","author":"Andera","year":"2011","journal-title":"Mol Immunol"},{"key":"24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1074-7613(01)00162-5","article-title":"Enhanced CD4+ T cell proliferation and Th2 cytokine production in DR6-deficient mice","volume":"15","author":"Yang","year":"2001","journal-title":"Immunity"},{"key":"25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1084\/jem.194.10.1441","article-title":"Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6-deficient mice","volume":"194","author":"Dixit","year":"2001","journal-title":"J Exp Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Paulsen","year":"2012","journal-title":"Nat Genet"},{"key":"27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Yang","year":"2012","journal-title":"Nature"},{"key":"28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1101\/gad.11.8.957","article-title":"Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway","volume":"11","author":"Sherr","year":"1997","journal-title":"Genes Dev"},{"key":"29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neo.2014.07.002","article-title":"SAMSN1 is a tumor suppressor gene in multiple myeloma","volume":"16","author":"Zannettino","year":"2014","journal-title":"Neoplasia"},{"key":"30","doi-asserted-by":"crossref","first-page":"e0127828","DOI":"10.1371\/journal.pone.0127828","article-title":"Whole Genome Sequence of Multiple Myeloma-Prone C57BL\/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types","volume":"10","author":"Hurchla","year":"2015","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/epi.14.80","article-title":"Genetic alterations of DNA methylation machinery in human diseases","volume":"7","author":"Chen","year":"2015","journal-title":"Epigenomics"},{"key":"32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Reardon","year":"2009","journal-title":"N Engl J Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2009-11-250878","article-title":"Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value","volume":"116","author":"Valk","year":"2010","journal-title":"Blood"},{"key":"34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/leu.2010.52","article-title":"Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS\/myeloproliferative neoplasms","volume":"24","author":"Bernard","year":"2010","journal-title":"Leukemia"},{"key":"35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Bernard","year":"2012","journal-title":"N Engl J Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Opolon","year":"2011","journal-title":"Cancer Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Link","year":"2014","journal-title":"Nat Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Levine","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2013.12.016","article-title":"Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance","volume":"14","author":"Zhang","year":"2014","journal-title":"Cell Stem Cell"},{"key":"40","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.1400839","article-title":"Gene targeting RhoA reveals its essential role in coordinating mitochondrial function and thymocyte development","volume":"193","author":"Guo","year":"2014","journal-title":"J Immunol"},{"key":"41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaci.2015.05.004","article-title":"RhoA orchestrates glycolysis for TH2 cell differentiation and allergic airway inflammation","volume":"137","author":"Guo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"42","article-title":"Frequent CTLA4-CD28 gene fusion in diverse types of T cell lymphoma","author":"Lee","year":"2016","journal-title":"Haematologica"},{"key":"43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Xue","year":"2015","journal-title":"Leukemia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T17:06:30Z","timestamp":1589130390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,3,14]]}},"alternative-id":["14846","28148900"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14846","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}